Alunacedase alfa
阿鲁纳西酶 α
Report date: 2025/12/26 20:01:33
Base Information
Drug NameAlunacedase alfa
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[7]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[9]
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesApeiron Biologics
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcApeiron Biologics
Active IndicationsN/A
Inactive Indications +[7]
Other Information
ATC CodeN/A
Related LinksN/A